Proxy Votes Now

Home › Funds › Charles Schwab › Schwab Small-Cap Equity Fund

Schwab Small-Cap Equity Fund (SWSCX) proxy voting record 2023-2024

Fund family: Charles Schwab · Filed by SCHWAB CAPITAL TRUST (CIK 904333) · SEC series S000005516

Ticker: SWSCX (C000015017)

2023-20242024-20252025-2026

“With management” uses the answer Form N-PX asks for on every vote (Item 1(l)): whether the vote went with or against management’s recommendation, read from the records of the way the fund voted, and only where the filer’s records pass the site’s consistency check: 2,598 with, 195 against, 2 abstentions (in the total, not counted as with management); 2 votes not determined (2 where the filing records no recommendation); 3 split votes are in neither count. Shareholder proposals: 5 FOR, 8 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Charles Schwab as a whole

The same two figures as Charles Schwab’s manager page (426,610 ballot items across 70 funds and accounts), counted the same way for this fund.

2023-2024This fundItemsCharles SchwabItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)93.4%2,71192.3%343,751
Backed environmental and social shareholder proposals at US companiesn/a79.4%5,164

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,961134
Say-on-Pay34723
Audit-related3204
Compensation1128
Corporate Governance5816
Capital Structure336
Shareholder Rights and Defenses202
Extraordinary Transactions60
Diversity, Equity, and Inclusion31
Other Social Issues31

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
MODINE MANUFACTURING CO.August 17, 2023$15M61
AMYLYX PHARMACEUTICALS INC.June 6, 2024$14M50
EMCOR GROUP INC.June 6, 2024$13M100
RIGEL PHARMACEUTICALS INC.May 24, 2024$12M70
CAREDX INC.June 13, 2024$11M60
STERLING INFRASTRUCTURE INC.May 9, 2024$11M110
COMFORT SYSTEMS USA INC.May 17, 2024$11M120
MEDPACE HOLDINGS INC.May 17, 2024$10M50

Notable votes against management

MeetingCompanyProposalFundMgmt
August 17, 2023MODINE MANUFACTURING CO.Election of Director: Ms. Marsha C. WilliamsAgainstFor
May 15, 2024BANKUNITED INC.Advisory Vote To Approve The Compensation Of The Company's Named Executive Officers.AgainstFor
June 20, 2024PROTAGONIST THERAPEUTICS INC.Elect Sarah A. O'DowdWithholdFor
August 29, 2023COMMVAULT SYSTEMS INC.To vote to amend Commvault s Amended and Restated Certificate of Incorporation to include officer exculpation.AgainstFor
June 14, 2024APPFOLIO INC.Elect Timothy BlissWithholdFor
June 14, 2024APPFOLIO INC.Advisory approval of the compensation of our named executive officers.WithholdFor
June 14, 2024AURINIA PHARMACEUTICALS INC.To approve, on a non-binding advisory basis, a say on pay resolution regarding the Company s executive compensation set forth in the Company s Proxy Statement/Circular.AgainstFor
May 16, 2024ENACT HOLDINGS INC.Approval Of An Amendment To The Corporation's Certificate Of Incorporation To Adopt Provisions Limiting The Liability Of Certain Officers As Permitted Under Delaware Law.AgainstFor
June 14, 2024TG THERAPEUTICS INC.Elect Laurence N. CharneyWithholdFor
June 14, 2024TG THERAPEUTICS INC.Elect Yann EchelardWithholdFor
May 29, 2024ACADIA PHARMACEUTICALS INC.To elect three Class II directors to hold office until the Company's 2027 Annual Meeting of Stockholder: Daniel B. SolandWithholdFor
September 26, 2023MUELLER INDUSTRIES INC.Approve the amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock by 150,000,000 shares.AgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2023-2024), and how the fund voted the items on its ballot.

Every vote, 2023-2024

The vote-by-vote list is kept for the latest season, 2025-2026. Every vote of 2023-2024 is in the interactive database, company by company, under Charles Schwab.

About this fund’s record

In the 2023-2024 proxy season, Schwab Small-Cap Equity Fund (SWSCX) voted at 329 shareholder meetings of 322 companies, on 2,865 ballot items in all. On the 2,795 items where its filing records whether the vote went with or against management's recommendation, the fund voted with management on 93.0% and against it 195 times. Its most frequent area of disagreement was director elections (134 of its votes against management). It voted on 13 shareholder proposals. It voted FOR the board's own proposals more often than Charles Schwab's funds as a whole (93.4% against 92.3%). 1 of its meetings was contested.

About this page

Correction (20 November 2026): Until this date, the “votes against management” figures on /trends and on fund pages were miscounted. Form N-PX asks each fund to record whether each vote was for or against management’s recommendation; we had read that field as the recommendation itself. So a fund voting against a shareholder proposal, as the board recommended, was counted as voting against management, and a vote against a board nominee was counted as with management. Figures now use the field as the form defines it, only for filers whose records pass our consistency check; other votes show as “not determined”. Example: mega caps, 2026: 16.4% before, 8.6% now. Vanguard 500 Index: 67.2% with management before, 97.5% now.

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 20, 2026; the family figures are those of Charles Schwab’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.